Literature DB >> 11070409

Obstructive jaundice, bacterial translocation and interdigestive small-bowel motility in rats.

V B Nieuwenhuijs1, J E van Dijk, H G Gooszen, L M Akkermans.   

Abstract

BACKGROUND/AIMS: Translocation of gut bacteria occurs in obstructive jaundice, the underlying mechanisms are unclear. We designed this experimental study to investigate the association between interdigestive motility and the pathogenesis of bacterial translocation during biliary obstruction.
METHODS: Rats were fitted with jejunal myoelectrodes for the measurement of the interdigestive migrating motor complex (MMC) and with two cannulas in the proximal common bile duct (CBD) for exteriorization of biliary flow. This allowed measurement of MMCs under control conditions with an intact enterohepatic circulation and during 3 days of CBD obstruction without surgical intervention. Mesenteric lymph nodes, liver, spleen and segments of the duodenum, the jejunum and the caecum were removed for microbial culturing.
RESULTS: The MMC cycle length increased from 17.3 min before CBD obstruction to 31.9, 34.1, and 25.3 min on days 1, 2 and 3, respectively, after CBD obstruction (p < 0.05 for all days). Bacterial levels in the jejunum were significantly higher in CBD-obstructed rats than in control rats. The translocation incidence was significantly higher in rats with CBD obstruction (6/8) than in control rats (1/8). The bacterial levels in the jejunum correlated significantly with the MMC cycle length (r = 0.60, p <0.05).
CONCLUSION: Experimental biliary obstruction is associated with disturbance of MMCs, small-bowel bacterial overgrowth and increased bacterial translocation. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11070409     DOI: 10.1159/000007824

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Intestinal failure in obstructive jaundice.

Authors:  Stelios F Assimakopoulos; Constantine E Vagianos; Aristides Charonis; Vassiliki N Nikolopoulou; Chrisoula D Scopa
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

2.  Effect of probiotic supplementation on bacterial translocation in common bile duct obstruction.

Authors:  Fatma Sarac; Tansu Salman; Feryal Gun; Alaaddin Celik; Nezahat Gurler; Semra Dogru Abbasoglu; Vakur Olgac; Ayse Saygili
Journal:  Pediatr Surg Int       Date:  2014-12-13       Impact factor: 1.827

Review 3.  Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.

Authors:  Bushra Aziz Malik; Yuan Y Xie; Eytan Wine; Hien Q Huynh
Journal:  Can J Gastroenterol       Date:  2011-01       Impact factor: 3.522

4.  Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.

Authors:  A Giacometti; O Cirioni; R Ghiselli; F Mocchegiani; G D'Amato; M Simona Del Prete; F Orlando; W Kamysz; J Lukasiak; V Saba; G Scalise
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

5.  Effects on bacterial translocation of high-fat enteral nutrition in bile duct ligated rats.

Authors:  Tufan Elipek; Nihat Zafer Utkan
Journal:  Balkan Med J       Date:  2012-09-01       Impact factor: 2.021

6.  The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis.

Authors:  Jordan E Fishman; Gal Levy; Vamsi Alli; Xiaozhong Zheng; Damian J Mole; Edwin A Deitch
Journal:  Shock       Date:  2014-09       Impact factor: 3.454

Review 7.  Murine Models of Acute Pancreatitis: A Critical Appraisal of Clinical Relevance.

Authors:  Pedro Silva-Vaz; Ana Margarida Abrantes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão
Journal:  Int J Mol Sci       Date:  2019-06-07       Impact factor: 5.923

Review 8.  The use of animal models to study bacterial translocation during acute pancreatitis.

Authors:  L P van Minnen; M Blom; H M Timmerman; M R Visser; H G Gooszen; L M A Akkermans
Journal:  J Gastrointest Surg       Date:  2007-03-07       Impact factor: 3.452

9.  Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949].

Authors:  Marc G H Besselink; Harro M Timmerman; Erik Buskens; Vincent B Nieuwenhuijs; Louis M A Akkermans; Hein G Gooszen
Journal:  BMC Surg       Date:  2004-09-29       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.